Atlas Trials

Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Clinical trial NCT02119468 · COMPLETED

Trial details

NCT number
NCT02119468
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory Plasma Cell MyelomaRecurrent Plasma Cell Myeloma
Start date
2014-06-30
Primary completion
2016-05-18
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.